Share of biotech medicines in development by therapeutic area in Spain 2021
Cancer was the therapeutic area that had the largest share of biotech drugs in development in Spain, with approximately 62 percent of the drugs investigated by multinational subsidiaries and 34 percent of national companies in 2021. Development of medicines for infections, including COVID-19, had a share of nine and 14 percent. In fact, according to a recent survey, around 45 percent biotechnology companies in Spain changed their line of research to COVID-19 during 2020.
